Edwards Lifesciences (EW -0.2%) estimates were raised at Goldman today, after the firm conducted...

|About: Edwards Lifesciences Corp (EW)|By:, SA News Editor

Edwards Lifesciences (EW -0.2%) estimates were raised at Goldman today, after the firm conducted a physicians survey regarding the company's Sapien Transcatheter Aortic Valve Implant in non-surgical population which confirmed demand should accelerate. The firm ups 2014 and 2015 estimates to reflect the anticipated market share gains.